PowerPoint Presentation
B CAPITAL OVERVIEW FOR BCG MDPS
May 2026
FOCUS:
TECH, HEALTHCARE, ENERGY
STAGE:
VENTURE + GROWTH
COME ENGAGE WITH US DURING THIS WEEK IN SAN FRANCISCO
B Capital team in attendance
JEFF JOHNSON
General Partner
Head of Energy
YAN-DAVID (YANDA)
General Partner
Technology / AI
TED HILL
General Partner,
CFO
ROBERT MITTENDORF
General Partner
Healthcare
RAJ GANGULY
Co-Founder & Co-CEO
KATE BECHTOLD
Managing Director,
Investor Relations &
Communications
Three sectors, one interconnected opportunity
Healthcare needs AI. AI needs energy.
B Capital is uniquely positioned at the intersection of all three sectors.
TECH
Increasing productivity
AI co-workers, infrastructure, developer tools, next-gen models
Key positions: Apptronik · Deferred · Oro Labs
HEALTHCARE
Transforming care
AI-driven diagnostics, drug discovery, clinical operations, payment infrastructure
Key positions: Precision Neuroscience · Labviva· Via Health
ENERGY
Powering AI
Grid infrastructure, clean power, and solutions for AI's massive energy demands
Key positions: Star Catcher · Overstory
B CAPITAL AT A GLANCE
AI driven investment firm · By founders, for founders · Global reach · Sector experts
~$11B
ASSETS UNDER MANAGEMENT¹
210+
PORTFOLIO COMPANIES⁴
GLOBAL LOCATIONS²
90+
BCG
TOTAL EMPLOYEES¹
STRATEGIC PARTNERSHIP³
Representative Investments¹²
Awards & Recognitions5,6,7,8,9,10,11
Top 20 Venture Capital firms
Most Prominent VCs in LA, Raj Ganguly
2025 Venture Vanguard, Howard Morgan
Top Healthcare Investors of 2025, Robert Mittendorff, MD
America’s Top Venture Capital Firms, 2025
Top 40 Under 40 Growth Investors of 2024, Adam Seabrook
OUR INVESTMENT APPROACH
ADVANTAGES
Focused funds
Global reach
Agile decision-making
MULTI-STAGE PLATFORM
Dedicated stage-based venture funds to support founders through the company-building lifecycle
| As of March 31, 2026 | Venture | Growth | Later-Stage | Strategic Growth |
|---|---|---|---|---|
| Fund Series | Ascent I, II, III¹ | Growth I, II, III, IV² | Opportunities I, II | |
| Stage Focus | Seed, Series A and B | Series B to Pre-IPO | in later-stage growth companies | |
| Total Commitments | ~$900M | ~$4.8B | ~$1.2B | |
| Portfolio Companies | 100+ | 120+ | 15 |
Active Co-investment Program Across Strategies
~$2.8B of Committed Capital
BCG STRATEGIC PARTNERSHIP
With BCG, B Capital has a unique advantage of world-leading industry insights
11K+
BCG Consultants Globally
10+ years
Strategic Partnership Duration with B Capital
Founder Intros
Access to top tier founders and
ability to introduce through BCG’s
active participation in the Tech
ecosystem
Customer Access
Introductions to top-tier founders in BCG's network
Introductions to targeted senior
executives at Fortune 1000
companies2
Strategy + AI Advice
BCG engagements completed
across portfolio companies. AI
Transformation, Go-to-market
strategy, pricing, market entry
Talent Pipeline
Ability to look to BCG alumni and
advisors for executive hiring. COO,
CFO, and go-to-market leadership
roles
SENIOR INVESTMENT TEAM
Experienced operators and investors across all three verticals
EXECUTIVE LEADERSHIP
Eduardo Saverin
Co-Founder & Co-CEO
Facebook Co-Founder
Raj Ganguly
Co-Founder & Co-CEO
Bain Capital
Howard Morgan
Co-founder & Chair
Renaissance Tech · First Round
SECTOR LEADERSHIP
215+
Total years investing
Yan-David Erlich
General Partner, Head of Tech
Focus: AI models & infrastructure, developer tools, AI co-workers
Robert Mittendorff, MD
General Partner, Head of Healthcare
Focus: Healthcare, digital health, bio-AI
Jeff Johnson
General Partner, Head of Energy
Focus: Grid infrastructure, clean power, energy-efficient solutions
PROPRIETARY AI INVESTMENT PLATFORM
Tools built by our AI team to drive faster more informed investment decisions
The Bee
AI Agent
Autonomous AI partner that executes actions across the investment workflow
- Automated company research
- Diligence synthesis
- Competitive analysis
- Portfolio monitoring alerts
- Meeting prep and follow-up
The Hive
AI Data Engine
Unified intelligence layer connecting all firm data for real-time insights
INVESTMENT OPPORTUNITIES FOR MDPS
BCG MDPs have preferential investment minimums starting at $100K commitment²
| ASCENT STRATEGY | GLOBAL GROWTH STRATEGY | |||
|---|---|---|---|---|
| Ascent Fund III | Emerging Asia Fund | Growth Fund IV | Healthcare Fund II | Energy AI Fund I |
| $400M | $350M | $1.25B | $250M | $350M |
| $447M | $250M | $1.06B | $140M | $118M |
CONSISTENTLY DRIVING ATTRACTIVE PERFORMANCE
| Vintage | Gross IRR | Net IRR | Gross MOIC | TVPI | DPI | |
|---|---|---|---|---|---|---|
| Ascent Fund I² | 2019 | 34.3% | 25.5% | 4.3x | 3.1x | 0.1x |
| Ascent Fund II | 2021 | 18.3% | 10.5% | 1.7x | 1.3x | 0.2x |
| Ascent Fund III | 2024 | 155.8% | 112.6% | 2.5x | 1.8x | 0.0x |
| Growth Fund I | 2016 | 15.1% | 9.9% | 2.1x | 1.6x | 0.9x |
| Growth Fund II | 2019 | 4.9% | 1.7% | 1.3x | 1.1x | 0.1x |
| Growth Fund III | 2021 | 8.8% | 4.8% | 1.3x | 1.1x | 0.1x |
| Growth Fund IV | 2025 | NM³ | NM³ | 2.4x | 2.2x | 0.0x |
| Healthcare Fund I | 2021 | 12.7% | 8.8% | 1.4x | 1.3x | 0.1x |
| Healthcare Fund II | 2025 | NM³ | NM³ | 1.0x | NM³ | NM³ |
| Energy AI Fund I | 2025 | NM³ | NM³ | 1.0x | NM³ | NM³ |
NOTES ON INVESTMENT PERFORMANCE
(1) Unless otherwise stated, the values of unrealized investments are based on the good faith estimates of the General Partner as of March 31, 2026, which is based on the best information available in the circumstances. The value of unrealized investments may incorporate assumptions made by B Capital and involves a significant degree of judgment, taking into account a combination of external and internal factors, which may be outside the control of B Capital.
(2) Realized value represents the sum of distributions, interest income and cash proceeds from dispositions of investments. Performance information for certain of the investments include amounts held in escrow or subject to holdback.
(3) Gross performance information does not reflect management fees or performance fees (i.e., carried interest) charged by B Capital, or any other expenses at the level of a B Capital fund borne indirectly by investors in such B Capital fund, which will reduce returns and in the aggregate are expected to be substantial.
ADDITIONAL NOTES ON ASCENT FUND I
(1) Data and analysis are estimated as of March 31, 2026 unless stated otherwise, and based on available information to the best knowledge of B Capital. B Capital supports a separate independent valuation process on a quarterly basis and the figures herein are derived independent of such quarterly valuation process.
(2) B Capital Partners Innovators Fund, L.P. (“Ascent Fund I”) was conceived as an internal fund that could serve as a possible pipeline for B Capital external funds comprised of external investors through toe–hold investments.
(3) For informational purposes only, investments have been represented herein as if they were still in Ascent Fund I.